Using Tversky Similarity Searches for Core Hopping: Finding the Needles in the Haystack

被引:21
作者
Senger, Stefan [1 ]
机构
[1] GlaxoSmithKline Inc, Med Res Ctr, Stevenage SG1 2NY, Herts, England
关键词
B-1 RECEPTOR ANTAGONISTS; CYCLOOXYGENASE-2; INHIBITORS; BIOLOGICAL EVALUATION; CANNABINOID RECEPTOR; 2,3-DIAMINOPYRIDINE; DISCOVERY; DESIGN; POTENT; COX-2;
D O I
10.1021/ci900092y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The combination of Daylight fingerprints and the Tversky coefficient is a powerful method for performing core hopping, that is, scaffold (or lead) hopping where the main structural difference between the query and bioactive target molecule is located in the central core of the molecular structure. However, a major disadvantage of this approach is the fact that a large number of false positives (in the context of core hopping) are retrieved. The tool we have developed and which is described here can be used to postprocess the hits from Daylight Tversky similarity searches by fragmenting the molecules and subsequently annotating them in a way that assists the users in removing false positives and enables them to better focus on molecules of interest. To validate our approach, we have selected four biological targets for which scaffold hopping examples have been reported. We present results from searches in databases containing published activity data and the subsequent analysis of the hits aimed at establishing the potential of our approach.
引用
收藏
页码:1514 / 1524
页数:11
相关论文
共 41 条
[1]  
ALANINE A, 2004, Patent No. 20040142922
[2]  
BABU YS, 2004, Patent No. 6699994
[3]   AN ALGORITHM FOR THE MULTIPLE COMMON SUBGRAPH PROBLEM [J].
BAYADA, DM ;
SIMPSON, RW ;
JOHNSON, AP ;
LAURENCO, C .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1992, 32 (06) :680-685
[4]  
BERGGREN AIK, 2004, Patent No. 02004058249
[5]  
Bohm Hans-Joachim, 2004, Drug Discov Today Technol, V1, P217, DOI 10.1016/j.ddtec.2004.10.009
[6]  
BRENDEL J, 2007, Patent No. 20070117807
[7]  
CARPINO PA, 2004, Patent No. 200402114855
[8]  
CASTLE NA, 1998, Patent No. 199804521
[9]  
DURAN CP, 1999, Patent No. 199914205
[10]   Discovery of pyrazine carboxamide CB1 antagonists: The introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series [J].
Ellsworth, Bruce A. ;
Wang, Ying ;
Zhu, Yeheng ;
Pendri, Annapurna ;
Gerritz, Samuel W. ;
Sun, Chongqing ;
Carlson, Kenneth E. ;
Kang, Liya ;
Baska, Rose A. ;
Yang, Yifan ;
Huang, Qi ;
Burford, Neil T. ;
Cullen, Mary Jane ;
Johnghar, Susan ;
Behnia, Kamelia ;
Pelleymounter, Mary Ann ;
Washburn, William N. ;
Ewing, William R. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) :3978-3982